Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovateltide in Traumatic Brain Injury
NCT07861126Phase 3Not yet recruiting
- Sponsor
- Pharmazz, Inc.
- Start
- Dec 2026
- Primary completion
- Feb 2028
01
Overview
A Phase 3 trial of sovateltide in traumatic brain injury (TBI), sponsored by Pharmazz, Inc.. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
sovateltide
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT07861126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07861126.